Cargando…

Effects of Long-Term Fenofibrate Treatment on Markers of Renal Function in Type 2 Diabetes: The FIELD Helsinki substudy

OBJECTIVE: Although fenofibrate was associated with less progression of albuminuria in the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study, it is unknown if it has any effect on renal function. We explored if there were changes in commonly available markers of renal function du...

Descripción completa

Detalles Bibliográficos
Autores principales:	Forsblom, Carol, Hiukka, Anne, Leinonen, Eeva S., Sundvall, Jouko, Groop, Per-Henrik, Taskinen, Marja-Riitta
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2010
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809252/ https://www.ncbi.nlm.nih.gov/pubmed/19846798 http://dx.doi.org/10.2337/dc09-0621

Ejemplares similares

High Density Lipoprotein Structural Changes and Drug Response in Lipidomic Profiles following the Long-Term Fenofibrate Therapy in the FIELD Substudy
por: Yetukuri, Laxman, et al.
Publicado: (2011)

Apolipoprotein C‐III predicts cardiovascular events and mortality in individuals with type 1 diabetes and albuminuria
por: Jansson Sigfrids, Fanny, et al.
Publicado: (2021)

Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
por: Scott, Russell, et al.
Publicado: (2009)

ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan
por: Hiukka, Anne, et al.
Publicado: (2009)

Sphingomyelin and progression of renal and coronary heart disease in individuals with type 1 diabetes
por: Pongrac Barlovic, Drazenka, et al.
Publicado: (2020)

Fear of hypoglycaemia and self-management in type 1 diabetes
por: Ahola, Aila J., et al.
Publicado: (2016)

Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study
por: Harjutsalo, Valma, et al.
Publicado: (2011)

Heritability of Proliferative Diabetic Retinopathy
por: Hietala, Kustaa, et al.
Publicado: (2008)

The impact of diabetic nephropathy and severe diabetic retinopathy on chronic limb threatening ischemia risk in individuals with type 1 diabetes: a nationwide, population study
por: Harjutsalo, Valma, et al.
Publicado: (2023)

Perceived Stress and Adherence to the Dietary Recommendations and Blood Glucose Levels in Type 1 Diabetes
por: Ahola, Aila J., et al.
Publicado: (2020)

The impact of central obesity on the risk of hospitalization or death due to heart failure in type 1 diabetes: a 16-year cohort study
por: Parente, Erika B., et al.
Publicado: (2021)

Waist-Height Ratio and the Risk of Severe Diabetic Eye Disease in Type 1 Diabetes: A 15-Year Cohort Study
por: Parente, Erika B, et al.
Publicado: (2021)

Age at Onset and the Risk of Proliferative Retinopathy in Type 1 Diabetes
por: Hietala, Kustaa, et al.
Publicado: (2010)

Nut Consumption Is Associated with Lower Risk of Metabolic Syndrome and Its Components in Type 1 Diabetes
por: Ahola, Aila J., et al.
Publicado: (2021)

Baroreflex Sensitivity and Its Response to Deep Breathing Predict Increase in Blood Pressure in Type 1 Diabetes in a 5-Year Follow-Up
por: Rosengård-Bärlund, Milla, et al.
Publicado: (2011)

The cross-sectional associations between sense of coherence and diabetic microvascular complications, glycaemic control, and patients' conceptions of type 1 diabetes
por: Ahola, Aila J, et al.
Publicado: (2010)

Meal timing, meal frequency, and breakfast skipping in adult individuals with type 1 diabetes – associations with glycaemic control
por: Ahola, Aila J., et al.
Publicado: (2019)

Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes
por: Januszewski, Andrzej S., et al.
Publicado: (2021)

Effect of Fenofibrate Medication on Renal Function
por: Kim, Sungjong, et al.
Publicado: (2017)

Fenofibrate-induced renal dysfunction, yes or no?
por: Emami, Fatemeh, et al.
Publicado: (2020)

Response to Comment on: Lassenius et al. Bacterial Endotoxin Activity in Human Serum Is Associated With Dyslipidemia, Insulin Resistance, Obesity, and Chronic Inflammation. Diabetes Care 2011;34:1809–1815
por: Lassenius, Mariann I., et al.
Publicado: (2012)

Symptoms of depression are associated with reduced leisure-time physical activity in adult individuals with type 1 diabetes
por: Ahola, Aila J., et al.
Publicado: (2021)

Dietary intake and hospitalisation due to diabetic ketoacidosis and hypoglycaemia in individuals with type 1 diabetes
por: Ahola, Aila J., et al.
Publicado: (2021)

A1C Variability Predicts Incident Cardiovascular Events, Microalbuminuria, and Overt Diabetic Nephropathy in Patients With Type 1 Diabetes
por: Wadén, Johan, et al.
Publicado: (2009)

Relationship between ABO blood groups and cardiovascular disease in type 1 diabetes according to diabetic nephropathy status
por: Parente, Erika B., et al.
Publicado: (2020)

Helsinki, pt.1
por: CERN. Geneva. Audiovisual Unit
Publicado: (1994)

Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?
por: Taskinen, Marja-Riitta, et al.
Publicado: (2016)

Latent Autoimmune Diabetes in Adults Differs Genetically From Classical Type 1 Diabetes Diagnosed After the Age of 35 Years
por: Andersen, Mette K., et al.
Publicado: (2010)

Decline in the Cumulative Incidence of Severe Diabetic Retinopathy in Patients With Type 1 Diabetes
por: Kytö, Janne P., et al.
Publicado: (2011)

Serum Lipopolysaccharide Activity Is Associated With the Progression of Kidney Disease in Finnish Patients With Type 1 Diabetes
por: Nymark, Mariann, et al.
Publicado: (2009)

Proteases and Protease Inhibitors of Urinary Extracellular Vesicles in Diabetic Nephropathy
por: Musante, Luca, et al.
Publicado: (2015)

Endotoxins are associated with visceral fat mass in type 1 diabetes
por: Lassenius, Mariann I., et al.
Publicado: (2016)

Metabolomic Profile Predicts Development of Microalbuminuria in Individuals with Type 1 Diabetes
por: Haukka, Jani K., et al.
Publicado: (2018)

Dietary patterns reflecting healthy food choices are associated with lower serum LPS activity
por: Ahola, Aila J, et al.
Publicado: (2017)

Waist-height ratio and waist are the best estimators of visceral fat in type 1 diabetes
por: Parente, Erika B., et al.
Publicado: (2020)

Decreased plasma kallikrein activity is associated with reduced kidney function in individuals with type 1 diabetes
por: Härma, Mari-Anne, et al.
Publicado: (2020)

Urinary Liver-Type Fatty Acid–Binding Protein and Progression of Diabetic Nephropathy in Type 1 Diabetes
por: Panduru, Nicolae M., et al.
Publicado: (2013)

Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]
Publicado: (2005)

Metabolic Syndrome as a Risk Factor for Cardiovascular Disease, Mortality, and Progression of Diabetic Nephropathy in Type 1 Diabetes
por: Thorn, Lena M., et al.
Publicado: (2009)

Bacterial infections in patients with type 1 diabetes: a 14-year follow-up study
por: Simonsen, Johan R, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_b5314kdquja59pgs6vunhm2t26